811 related articles for article (PubMed ID: 24930952)
1. Mass spectrometry and redox proteomics: applications in disease.
Butterfield DA; Gu L; Di Domenico F; Robinson RA
Mass Spectrom Rev; 2014; 33(4):277-301. PubMed ID: 24930952
[TBL] [Abstract][Full Text] [Related]
2. Redox proteomics: from bench to bedside.
Ckless K
Adv Exp Med Biol; 2014; 806():301-17. PubMed ID: 24952188
[TBL] [Abstract][Full Text] [Related]
3. Redox Proteomes in Human Physiology and Disease Mechanisms.
Mannaa A; Hanisch FG
J Proteome Res; 2020 Jan; 19(1):1-17. PubMed ID: 31647248
[TBL] [Abstract][Full Text] [Related]
4. Redox proteomics: Methods for the identification and enrichment of redox-modified proteins and their applications.
Lennicke C; Rahn J; Heimer N; Lichtenfels R; Wessjohann LA; Seliger B
Proteomics; 2016 Jan; 16(2):197-213. PubMed ID: 26508685
[TBL] [Abstract][Full Text] [Related]
5. Proteomics identification of oxidatively modified proteins in brain.
Sultana R; Perluigi M; Butterfield DA
Methods Mol Biol; 2009; 564():291-301. PubMed ID: 19544029
[TBL] [Abstract][Full Text] [Related]
6. Plant redox proteomics.
Navrot N; Finnie C; Svensson B; Hägglund P
J Proteomics; 2011 Aug; 74(8):1450-62. PubMed ID: 21406256
[TBL] [Abstract][Full Text] [Related]
7. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.
Butterfield DA; Perluigi M; Reed T; Muharib T; Hughes CP; Robinson RA; Sultana R
Antioxid Redox Signal; 2012 Dec; 17(11):1610-55. PubMed ID: 22115501
[TBL] [Abstract][Full Text] [Related]
8. ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications.
Moldogazieva NT; Mokhosoev IM; Feldman NB; Lutsenko SV
Free Radic Res; 2018 May; 52(5):507-543. PubMed ID: 29589770
[TBL] [Abstract][Full Text] [Related]
9. Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.
Gu L; Robinson RA
Proteomics Clin Appl; 2016 Dec; 10(12):1159-1177. PubMed ID: 27666938
[TBL] [Abstract][Full Text] [Related]
10. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in the aging murine olfactory bulb: redox proteomics and cellular localization.
Vaishnav RA; Getchell ML; Poon HF; Barnett KR; Hunter SA; Pierce WM; Klein JB; Butterfield DA; Getchell TV
J Neurosci Res; 2007 Feb; 85(2):373-85. PubMed ID: 17131389
[TBL] [Abstract][Full Text] [Related]
12. Thiol-based redox proteomics in cancer research.
Yuan K; Liu Y; Chen HN; Zhang L; Lan J; Gao W; Dou Q; Nice EC; Huang C
Proteomics; 2015 Jan; 15(2-3):287-99. PubMed ID: 25251260
[TBL] [Abstract][Full Text] [Related]
13. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease.
Sultana R; Butterfield DA
Methods Mol Biol; 2009; 566():123-35. PubMed ID: 20058169
[TBL] [Abstract][Full Text] [Related]
14. Detection of 4-hydroxy-2-nonenal- and 3-nitrotyrosine-modified proteins using a proteomics approach.
Sultana R; Reed T; Butterfield DA
Methods Mol Biol; 2009; 519():351-61. PubMed ID: 19381594
[TBL] [Abstract][Full Text] [Related]
15. ROSics: chemistry and proteomics of cysteine modifications in redox biology.
Kim HJ; Ha S; Lee HY; Lee KJ
Mass Spectrom Rev; 2015; 34(2):184-208. PubMed ID: 24916017
[TBL] [Abstract][Full Text] [Related]
16. Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics.
Calabrese V; Dattilo S; Petralia A; Parenti R; Pennisi M; Koverech G; Calabrese V; Graziano A; Monte I; Maiolino L; Ferreri T; Calabrese EJ
Free Radic Res; 2015 May; 49(5):511-24. PubMed ID: 25824967
[TBL] [Abstract][Full Text] [Related]
17. Proteomic detection of nitroproteins as potential biomarkers for cardiovascular disease.
Aslan M; Dogan S
J Proteomics; 2011 Oct; 74(11):2274-88. PubMed ID: 21640858
[TBL] [Abstract][Full Text] [Related]
18. Nonenzymatic post-translational modifications in peptides by cold plasma-derived reactive oxygen and nitrogen species.
Wenske S; Lackmann JW; Bekeschus S; Weltmann KD; von Woedtke T; Wende K
Biointerphases; 2020 Nov; 15(6):061008. PubMed ID: 33238712
[TBL] [Abstract][Full Text] [Related]
19. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
Polidori MC; Griffiths HR; Mariani E; Mecocci P
Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
[TBL] [Abstract][Full Text] [Related]
20. Gel-free proteomic methodologies to study reversible cysteine oxidation and irreversible protein carbonyl formation.
Boronat S; García-Santamarina S; Hidalgo E
Free Radic Res; 2015 May; 49(5):494-510. PubMed ID: 25782062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
